|
|
||||||||
Journal of Lipid Research, Vol 37, 673-683, Copyright © 1996 by Lipid Research, Inc.
MG Sorci-Thomas, JS Parks, MW Kearns, GN Pate, C Zhang and MJ Thomas
To facilitate the investigation of apoA-I structure:function relationships
as they relate to LCAT activation and lipid binding, we have developed an
apoA-I baculoviral expression and purification system that yields milligram
quantities of wild-type or mutant proapoA-I. Baculovirus-infected Sf-9
cells, grown in suspension, were found to secrete high levels of human
wild-type (40-50 mg/l) or mutant apoA-I protein (1-38 mg/l), which was
determined to be > 95% pure following a two-step purification procedure.
In the case of wild-type apoA-I, ELISA showed that approximately 13-18% of
the total protein secreted into the culture medium was apoA-I. To isolate
pure protein from culture medium, 72 h post-infection medium was subjected
to preparative reverse phase high performance liquid chromatography (HPLC),
followed by DEAE ion- exchange chromatography. Purity and molecular size
determination of wild-type proapoA-I protein was verified by SDS
polyacrylamide gel electrophoresis, electrospray mass spectrometry, and
N-terminal sequencing. In addition, recombinant discoidal
apoA-I:phospholipid complexes prepared from wild-type or plasma apoA-I
showed similar particle size and LCAT activation properties. To fully
characterize the utility of this expression system, the expression levels
of various mutant apoA-I proteins were compared to wild-type. Despite a
lower production level seen with selected apoA-I mutants, milligram
quantities of these purified mutant proteins were also obtained. In
summary, we show that baculovirus-derived wild-type proapoA-I shows
properties similar to plasma apoA-I relative to recombinant HDL formation,
LCAT reactivity, and alpha-helical content. In addition, we show that a
variety of mutant forms of human proapoA-I can be expressed and purified in
abundant quantity from baculoviral-infected Sf-9 cells.
ARTICLES
High level secretion of wild-type and mutant forms of human proapoA-I using baculovirus-mediated Sf-9 cell expression
Department of Comparative Medicine, Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, NC 27157-1040, USA.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
S. Bhat, M. G. Sorci-Thomas, E. T. Alexander, M. P. Samuel, and M. J. Thomas Intermolecular Contact between Globular N-terminal Fold and C-terminal Domain of ApoA-I Stabilizes Its Lipid-bound Conformation: STUDIES EMPLOYING CHEMICAL CROSS-LINKING AND MASS SPECTROMETRY J. Biol. Chem., September 23, 2005; 280(38): 33015 - 33025. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bhat, M. Zabalawi, M. C. Willingham, G. S. Shelness, M. J. Thomas, and M. G. Sorci-Thomas Quality control in the apoA-I secretory pathway: deletion of apoA-I helix 6 leads to the formation of cytosolic phospholipid inclusions J. Lipid Res., July 1, 2004; 45(7): 1207 - 1220. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Ahmed, A. Ravandi, G. F Maguire, A. Kuksis, and P. W Connelly Formation of apolipoprotein AI-phosphatidylcholine core aldehyde Schiff base adducts promotes uptake by THP-1 macrophages Cardiovasc Res, June 1, 2003; 58(3): 712 - 720. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Chroni, T. Liu, I. Gorshkova, H.-Y. Kan, Y. Uehara, A. von Eckardstein, and V. I. Zannis The Central Helices of ApoA-I Can Promote ATP-binding Cassette Transporter A1 (ABCA1)-mediated Lipid Efflux. AMINO ACID RESIDUES 220-231 OF THE WILD-TYPE ApoA-I ARE REQUIRED FOR LIPID EFFLUX IN VITRO AND HIGH DENSITY LIPOPROTEIN FORMATION IN VIVO J. Biol. Chem., February 21, 2003; 278(9): 6719 - 6730. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Liu, M. Krieger, H.-Y. Kan, and V. I. Zannis The Effects of Mutations in Helices 4 and 6 of ApoA-I on Scavenger Receptor Class B Type I (SR-BI)-mediated Cholesterol Efflux Suggest That Formation of a Productive Complex between Reconstituted High Density Lipoprotein and SR-BI Is Required for Efficient Lipid Transport J. Biol. Chem., June 7, 2002; 277(24): 21576 - 21584. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Reschly, M. G. Sorci-Thomas, W. S. Davidson, S. C. Meredith, C. A. Reardon, and G. S. Getz Apolipoprotein A-I alpha -Helices 7 and 8 Modulate High Density Lipoprotein Subclass Distribution J. Biol. Chem., March 15, 2002; 277(12): 9645 - 9654. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-h. Li, M. J. Thomas, W. Pan, E. Alexander, M. Samuel, and M. G. Sorci-Thomas Preparation and incorporation of probe-labeled apoA-I for fluorescence resonance energy transfer studies of rHDL J. Lipid Res., December 1, 2001; 42(12): 2084 - 2091. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-H. Cho, D. M. Durbin, and A. Jonas Role of individual amino acids of apolipoprotein A-I in the activation of lecithin:cholesterol acyltransferase and in HDL rearrangements J. Lipid Res., March 1, 2001; 42(3): 379 - 389. [Abstract] [Full Text] |
||||
![]() |
M. G. Sorci-Thomas, M. Thomas, L. Curtiss, and M. Landrum Single Repeat Deletion in ApoA-I Blocks Cholesterol Esterification and Results in Rapid Catabolism of Delta 6 and Wild-type ApoA-I in Transgenic Mice J. Biol. Chem., April 14, 2000; 275(16): 12156 - 12163. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Han, J. Sasaki, A. Matsunaga, H. Hakamata, W. Huang, M. Ageta, T. Taguchi, T. Koga, M. Kugi, S. Horiuchi, et al. A Novel Mutant, ApoA-I Nichinan (Glu235->0), Is Associated With Low HDL Cholesterol Levels and Decreased Cholesterol Efflux From Cells Arterioscler. Thromb. Vasc. Biol., June 1, 1999; 19(6): 1447 - 1455. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Sorci-Thomas, L. Curtiss, J. S. Parks, M. J. Thomas, M. W. Kearns, and M. Landrum The Hydrophobic Face Orientation of Apolipoprotein A-I Amphipathic Helix Domain 143-164 Regulates Lecithin:Cholesterol Acyltransferase Activation J. Biol. Chem., May 8, 1998; 273(19): 11776 - 11782. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Sorci-Thomas, L. Curtiss, J. S. Parks, M. J. Thomas, and M. W. Kearns Alteration in Apolipoprotein A-I 22-Mer Repeat Order Results in a Decrease in Lecithin:Cholesterol Acyltransferase Reactivity J. Biol. Chem., March 14, 1997; 272(11): 7278 - 7284. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Sviridov, L. E. Pyle, and N. Fidge Efflux of Cellular Cholesterol and Phospholipid to Apolipoprotein A-I Mutants J. Biol. Chem., December 27, 1996; 271(52): 33277 - 33283. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. N. Liadaki, T. Liu, S. Xu, B. Y. Ishida, P. N. Duchateaux, J. P. Krieger, J. Kane, M. Krieger, and V. I. Zannis Binding of High Density Lipoprotein (HDL) and Discoidal Reconstituted HDL to the HDL Receptor Scavenger Receptor Class B Type I. EFFECT OF LIPID ASSOCIATION AND APOA-I MUTATIONS ON RECEPTOR BINDING J. Biol. Chem., July 7, 2000; 275(28): 21262 - 21271. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-h. Li, D. S. Lyles, M. J. Thomas, W. Pan, and M. G. Sorci-Thomas Structural Determination of Lipid-bound ApoA-I Using Fluorescence Resonance Energy Transfer J. Biol. Chem., November 17, 2000; 275(47): 37048 - 37054. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Ahmed, A. Ravandi, G. F. Maguire, A. Emili, D. Draganov, B. N. L. Du, A. Kuksis, and P. W. Connelly Apolipoprotein A-I Promotes the Formation of Phosphatidylcholine Core Aldehydes That Are Hydrolyzed by Paraoxonase (PON-1) during High Density Lipoprotein Oxidation with a Peroxynitrite Donor J. Biol. Chem., June 29, 2001; 276(27): 24473 - 24481. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |